SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Terra Tech Corp (OTCMKTS:TRTC) reported that it enrolled for the services of ‘1868 Public Affairs’ to move forward with its process to obtain New Jersey Medical Marijuana License. 1868 Public Affairs comes in the list of New Jersey’s prominent public affairs firms. The entity brings extensive experience in successfully working for their clients across all departments and branches of the state government.

The plans

If 1868 Public Affairs and Terra Tech are successful, the company will be able to transform its state-of-the-art flagship greenhouse into the most environmentally friendly medical pot production facility in New Jersey. It will help ensure that there is adequate medical marijuana to fulfill the demand from patients in the state and obtain much needed access via a professionally operated dispensary.

The expert call

Derek Peterson, the CEO of Terra Tech Corp (OTCMKTS:TRTC), said that they are confident that the leading public affairs entity will tirelessly advocate on company’s behalf and also on behalf of the people who depend on medical marijuana. The objective is to make certain that patients get the highest quality medical marijuana products at the best possible rates.

The goal

The hydroponic greenhouse of company can produce premium quality product, using just a fraction of the total energy of indoor cultivation facilities. The CEO concluded that obtaining a New Jersey Medical Marijuana License is of top-most priority and they are allocating the needed resources to reach that goal. 1868 Public Affairs will work directly with company’s East Coast cannabis expert team including Evan Nison, Ken Vande Vrede and Michael James. The management will release additional updates related to the New Jersey license in the near future.​

In last trading session, the stock price of Terra Tech jumped more than 3% to close the trading session at $0.131.The gains came at a share volume of 1.33 million compared to monthly average share volume of 1.38 million.